AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
Migrate infobox: document_type -> document_category; add specific form as document_type
 
(7 intermediate revisions by the same user not shown)
Line 4:
| period = FY
| period_label = FY25
| document_typedocument_category = Analyst presentation
| publication_date = 2026-02-26
| language = English
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| archive_file = File:AXA-2025-FY-Earnings_presentation.md
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
Line 19 ⟶ 18:
=== Full Year 2025 earnings presentation ===
 
* '''PresentationAXA date'Full Year 2025'' earnings presentation delivered on February 26, 2026 <sup>p. 1</sup>
* '''Company''' AXA <sup>p. 1</sup>
 
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
 
* '''Forward-looking statements''' include predictions of future events, trends, plans, expectations, or objectives based on Management's current views and subject to change <sup>p. 2</sup>.
* '''UnderlyingExpected EPS''' (UEPS) growth guidance'' for 2026 is provided as one-off guidance in the context of the lastfinal year of the Group's current strategic plan <sup>p. 2</sup>.
* '''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document for the year ended December 31, 2024 <sup>p. 2</sup>.
* '''Alternative performance measures''' (APMs) used by management include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
 
=== Table of contents ===
 
* '''FY25 Highlights''' presented by Thomas Buberl, Group CEO <sup>p. 3, 4</sup>
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 3, 9</sup>
* '''FY25 Financial Performance''' presented by Alban de Mailly Nesle, Group CFO <sup>p. 3, 13</sup>
 
== FY25 Highlights ==
 
* Section divider slide for '''SessionFY25 presenter'Highlights'', presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
 
=== Full Year 2025 | Excellent performance ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
! class="col-m" style="text-align:right" | Value
|-
| style="text-align:left" | Revenues growth vs. FY24
| class="col-m" style="text-align:right" | +6% vs. FY24
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
| class="col-m" style="text-align:right" | +8% vs. FY24
|-
| style="text-align:left" | Return on equity (ROE)
| class="col-m" style="text-align:right" | 16%
|-
| style="text-align:left" | Solvency II ratio
| class="col-m" style="text-align:right" | 224%
|-
| style="text-align:left" | ShareholderDPS valuegrowth
| class="col-m" style="text-align:right" | +8% DPS growth and EUR 1.25bn annual share buyback
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | EarningsUnderlying guidanceEPS outlook for 2026
| class="col-m" style="text-align:right" | Confident to deliver underlying EPS growth at the upperUpper end of 6%-8% target range for 2026
|}
</div>
* Dividend proposedproposal bybased AXA'son Board of Directors' recommendation on February 25, 2026, subject to approval by the Shareholders' Annual General Meeting approval on April 30, 2026.
* Share buyback approved by AXA'sthe Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable., subject to market conditions
 
=== Executing the plan on growth, margin and efficiency ===
Line 74 ⟶ 76:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings (constant FX), FY24 vs FY25 <sup>p. 6</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (LFLconstant FX)
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
Line 88 ⟶ 90:
|}
</div>
* TopHigh lineorganic growth: +6% LFLtop line growth, well balanced across lines: (P&C: +5%, Life: +9%, Health: +5%.)
* Record profitability: driven by furtherFurther margin expansion in P&C and L&H, alongside; improvement in efficiency.
* Scaling the business: through continuedContinued investments in growth and technology.
* EarningsConsistent earnings growth delivered consistently while enhancing reserve prudence.
 
=== Diversified franchise, well positioned in an attractive industry ===
Line 97 ⟶ 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Business mix (FY25 grossGross written premium split (FY25, excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 108 ⟶ 110:
|-
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|}
</div>
 
* '''Secular trends''' fuelingfuel demand across businesses:, driven by protection gaps and emerging corporate risks, as well as demographics driving demand for private retirement and healthcare
* ''Our right to win'' is supported by four strategic pillars:
** Protection gaps and emerging corporate risks driving SME & Mid-market and Large & Specialty <sup>p. 7</sup>
** Leading brand & high customer NPS
** Demographics driving demand for private retirement and healthcare driving Life and Health <sup>p. 7</sup>
** Strong and diversified distribution
* '''Our right to win''' supported by four strategic pillars:
** Technical expertise to price & underwrite risks
** Leading brand & high customer NPS <sup>p. 7</sup>
** Scale offering cost advantage
** Strong and diversified distribution <sup>p. 7</sup>
** Technical expertise to price & underwriting risks <sup>p. 7</sup>
** Scale offering cost advantage <sup>p. 7</sup>
 
=== Laying the foundation for the next plan ===
 
* '''Strategic pillars''' established to lay the foundation for the next plan:
** ''Clear tech'' and AI roadmap <sup>p. 8</sup>
** ''Driving efficiency'' across operations <sup>p. 8</sup>
** ''Enhancing capital'' allocation discipline <sup>p. 8</sup>
** ''Building resilience'' across the business <sup>p. 8</sup>
* '''Earnings growth''' sustainabilityoutlook supported by strong foundations, providing confidence in sustaining earnings growth <sup>p. 8</sup>
 
=== SectionBusiness dividerPerformance ===
 
=== FY25 business performance ===
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>
 
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
== FY25 Business Performance ==
 
=== Strong delivery across our businesses ===
 
* ''Premium growth basis'': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* ''Earnings growth basis'': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Gross written premiums and underlying earnings by region FY25 <sup>p. 10</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:rightleft" | %Region (share of total GWP¹)
! class="col-sm" style="text-align:right" | GWPGross written premiums
! class="col-sm" style="text-align:right" | GWPUnderlying change LFLearnings
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | Underlying earnings change LFL
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" | 27+6% to EUR 31bn
| class="col-m" style="text-align:right" | 31+7% to EUR 2.2bn
| style="text-align:right" | +6%
| style="text-align:right" | 2.2
| style="text-align:right" | +7%
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" | 38+6% to EUR 43bn
| class="col-m" style="text-align:right" | 43+9% to EUR 3.5bn
| style="text-align:right" | +6%
| style="text-align:right" | 3.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" | 17+4% to EUR 19bn
| class="col-m" style="text-align:right" | 19+9% to EUR 1.9bn
| style="text-align:right" | +4%
| style="text-align:right" | 1.9
| style="text-align:right" | +9%
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" | 18+13% to EUR 20bn
| class="col-m" style="text-align:right" | 20+6% to EUR 1.5bn
| style="text-align:right" | +13%
| style="text-align:right" | 1.5
| style="text-align:right" | +6%
|}
</div>
Line 185 ⟶ 175:
=== P&C | Strong margins, confidence in sustaining growth ===
 
* ''Gross written premiums'' (GWP) reached EUR 58bn <sup>p. 11</sup>.
<div style="overflow-x:auto">
* (donut) ''GWP mix'': Retail, AXA XL (Large & Specialty), SME & Mid-market — shares not labeled <sup>p. 11</sup>.
{| class="wikitable fintable"
|+** AXA XL GWP mixincludes AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>.
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
! style="text-align:left" | EUR billion
* ''Retail and SME & Mid-market'' strategic outlook:
! class="col-s" style="text-align:right" | GWP
** ''2025'': Growing volumes while expanding margins <sup>p. 11</sup>.
|-
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
| style="text-align:left" | Retail
* ''AXA XL (Large & Specialty)'' strategic outlook:
| style="text-align:right" | —
** ''2025'': Profitable growth with stable margins <sup>p. 11</sup>.
|-
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
| style="text-align:left" | SME & Mid-market
* ''Earnings drivers'' supporting performance:
| style="text-align:right" | —
** Continued progress on efficiency <sup>p. 11</sup>.
|-
** Higher investment income <sup>p. 11</sup>.
| style="text-align:left" | AXA XL (Large & Specialty)
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 58
|}
</div>
 
* AXA XL includes AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>
* '''Underlying earnings''' +9% LFL to EUR 5.9bn (reported change FY25 vs. FY24 at constant FX) <sup>p. 11</sup>
* '''Retail and SME & Mid-market''' strategic outlook:
** '''2025''': Growing volumes while expanding margins <sup>p. 11</sup>
** '''Beyond 2025''': Investing to improve customer retention & expanding distribution footprint <sup>p. 11</sup>
* '''AXA XL (Large & Specialty)''' strategic outlook:
** '''2025''': Profitable growth with stable margins <sup>p. 11</sup>
** '''Beyond 2025''': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>
* '''Strategic enablers''':
** Continued progress on efficiency <sup>p. 11</sup>
** Higher investment income <sup>p. 11</sup>
** Data & AI to further enhance customer experience & technical excellence <sup>p. 11</sup>
 
=== L&H | Good momentum, well positioned to capture growth opportunities ===
 
* ''Gross written premiums'' (GWP) reached EUR 57bn <sup>p. 12</sup>.
<div style="overflow-x:auto">
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
{| class="wikitable fintable"
|* ''Underlying earnings'' +7% GWPLFL mixto byEUR Long-term3.5bn and(change Short-termFY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
* ''Long-term business'' strategic priorities:
! style="text-align:left" | EUR billion
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
! class="col-s" style="text-align:right" | GWP
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
|-
* ''Short-term business'' strategic priorities:
| style="text-align:left; font-weight:bold" | Total
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
| style="text-align:right; font-weight:bold" | 57
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
|-
* ''Strategic levers'' for growth and efficiency:
| style="text-align:left" | Long-term
** Focus on cost reduction <sup>p. 12</sup>.
| style="text-align:right" | —
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
|-
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
| style="text-align:left" | Short-term
 
| style="text-align:right" | —
== Financial Performance ==
|}
</div>
* '''Underlying earnings''' +7% LFL to EUR 3.5bn (reported change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>
* '''Long-term business''' strategic outlook:
** '''2025''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
** '''Beyond 2025''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
* '''Short-term business''' strategic outlook:
** '''2025''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
** '''Beyond 2025''': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
* '''Strategic enablers''':
** Focus on cost reduction <sup>p. 12</sup>
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
 
=== FY25 Financialfinancial Performanceperformance ===
 
* ''Section divider3'': slideFY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
Line 256 ⟶ 216:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP & Otherother Revenuesrevenues by linesegment, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
Line 293 ⟶ 253:
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>
* Growth supported by alternative capital <sup>p. 14</sup>
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 302 ⟶ 262:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio bridge, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | %Combined ratio
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Combined ratio
| style="text-align:right" | 91.0
| style="text-align:right" | 90.6
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.0%
|-
| style="text-align:left" | Expense ratio
| style="text-align:right" | 25.0%
| style="text-align:right" | 24.8%
|-
| style="text-align:left" | Nat Cat
| style="text-align:right" | 3.8%
| style="text-align:right" | 3.4%
|-
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" | Total combined ratio
| style="text-align:right; font-weight:bold" | 91.0%
| style="text-align:right; font-weight:bold" | 90.6%
|}
</div>
* Undiscounted CY loss ratio (ex Nat Cat) improved from:
* Better undiscounted current year loss ratio excluding Nat Cat from margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment <sup>p. 15</sup>
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment
* Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* Nat Cat charges below normalized load <sup>p. 15</sup>
* Nat Cat charges below normalized load
* Lower reliance on prior year reserve development <sup>p. 15</sup>
* Prior year reserve development shows lower reliance
* Taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
* Reserve prudence enhanced by taking advantage of a good year
 
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 372 ⟶ 333:
|}
</div>
* Underlying earnings grew +9% at constant FX to EUR 5,872m.
 
* '''Underwriting result''' improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>.
* '''Investment income''' increased reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>.
* '''UnwindInsurance finance expenses impacted by higher unwind of discount''' of claims reserves was higher, in line with guidance <sup>p. 16</sup>.
* '''Forex impact''' was unfavorable, notably due to USD depreciation vs. EUR <sup>p. 16</sup>.
* '''Underwriting result components''' include volume growth (+EUR 292m) and margin improvement (+EUR 189m) <sup>p. 16</sup>.
* '''Financial result components''' include investment income (+EUR 435m) and insurance finance expenses (-EUR 235m) <sup>p. 16</sup>.
* (waterfall) '''Underlying earnings bridge''' FY24→FY25: EUR 5,510m start → volume growth +EUR 292m → margin improvement +EUR 189m → investment income +EUR 435m → insurance finance expenses -EUR 235m → tax -EUR 169m → affiliates, FX & other -EUR 150m → EUR 5,872m end (+9% at constant FX) <sup>p. 16</sup>.
 
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 385 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life GWP &and other revenues by line, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Life GWP
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
Line 411 ⟶ 374:
| style="text-align:right" | -7%
|-
| style="text-align:left" | EmployeeHealth benefitsGWP
| style="text-align:right" | 17.5
| style="text-align:right" | 1219.90
| style="text-align:right" | +45%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 34.5
| style="text-align:right; font-weight:bold" | 37.5
| style="text-align:right; font-weight:bold" | +9%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Health GWP & other revenues, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Individual
Line 441 ⟶ 389:
| style="text-align:right" | +4%
|-
| style="text-align:left; font-weight:bold" | TotalEmployee Benefits GWP
| style="text-align:right; font-weight:bold" | 17.5
| style="text-align:right; font-weight:bold" | 1912.09
| style="text-align:right; font-weight:bold" | +54%
|}
</div>
Line 450 ⟶ 398:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | Protection flowsTotal
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | +4.9
|-
| style="text-align:left" | Health flows
| style="text-align:right" | —
| style="text-align:right" | +2.7
|-
| style="text-align:left" | Unit-linked flowsLinked
| style="text-align:right" | —
| style="text-align:right" | +1.5
|-
| style="text-align:left" | Capital light flowsG/A
| style="text-align:right" | —
| style="text-align:right" | +1.2
|-
| style="text-align:left" | Traditional G/A flows
| style="text-align:right" | —
| style="text-align:right" | -5.0
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | +1.5
| style="text-align:right; font-weight:bold" | +5.4
|}
</div>
Line 485 ⟶ 433:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP trend by segment, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" | Total PVEP
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
Line 496 ⟶ 449:
| style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-linkedLinked
| style="text-align:right" | —
| style="text-align:right" | 8.5
Line 510 ⟶ 463:
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|}
</div>
Line 520 ⟶ 468:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM (pre-tax)and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
Line 530 ⟶ 478:
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NBV (post-tax), FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | NBV (post-tax)
Line 548 ⟶ 486:
</div>
 
* '''PVEP''' was impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* '''NBV''' was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* '''NBV margin''' improved to: 4.54% (prior:in FY24 → 4.45%) in FY25 <sup>p. 18</sup>.
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 557 ⟶ 495:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ CSMContractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | CSMValue
|-
| style="text-align:left" | FY24
| style="text-align:right" | 33.6
|-
| style="text-align:left" | newNew business CSM
| style="text-align:right" | +2.2
|-
| style="text-align:left" | underlyingUnderlying return on in-force
| style="text-align:right" | +1.3
|-
Line 573 ⟶ 511:
| style="text-align:right" | -3.0
|-
| style="text-align:left" | economicEconomic variance
| style="text-align:right" | +0.6
|-
| style="text-align:left" | operatingOperating variance
| style="text-align:right" | -0.3
|-
| style="text-align:left" | affiliatesAffiliates, FX & other
| style="text-align:right" | -1.4
|-
Line 587 ⟶ 525:
</div>
 
* '''Normalized CSM''' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>.
* '''Economic variance''' reflectedreflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>.
* '''Operating variance''' was driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>.
* '''FX impact''' was mainly driven byfrom JPY and HKD depreciation <sup>p. 19</sup>.
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
* FY24 o/w Life EUR 25.8bn, Health EUR 7.7bn <sup>p. 19</sup>.
* FY25 o/w Life EUR 25.4bn, Health EUR 7.6bn <sup>p. 19</sup>.
* '''Normalized CSM growth''' was +2% <sup>p. 19</sup>.
 
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 603 ⟶ 539:
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
| style="text-align:left" | shortShort-term technical margin
| style="text-align:right" | +60
|-
| style="text-align:left" | longLong-term result incl. CSM release
| style="text-align:right" | +156
|-
| style="text-align:left" | financialFinancial result
| style="text-align:right" | -11
|-
| style="text-align:left" | taxTax, FX and others
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
 
* ''Underlying earnings'' +7% LFL to EUR 3,501m <sup>p. 20</sup>
* '''Short-term technical margin''' was strong, reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup>.
* '''LongShort-term results'technical margin'': wereEUR higher from an increase415m in CSMFY24 releaseto (+8%)EUR reflecting growth479m in reserve base, including from favorable equity market performance, and better marginsFY25 <sup>p. 20</sup>.
* FY25''Long-term (+7%result'' LFL)incl. CSM release: EUR 2,680m in FY24 to EUR 2,804m in FY25 <sup>p. 20</sup>.
* '''FY24Financial earnings mix'result'': short-term technical margin EUR 415m,975m long-termin result incl. CSMFY24 releaseto EUR 2,680m,946m financialin result EUR 975m, tax & others -EUR 748mFY25 <sup>p. 20</sup>.
* '''FY25Tax earnings& mix'others'': short-term technical margin EUR 479m, long-term748m resultin incl. CSMFY24 releaseto EUR 2,804m,-728m financialin result EUR 946m, tax & others -EUR 728mFY25 <sup>p. 20</sup>.
* '''Life underlying earnings''': FY24+4% to EUR 2.6bn7bn → FY25(prior: EUR 2.7bn (+4% LFL6bn) <sup>p. 20</sup>.
* '''Health underlying earnings''': FY24+17% to EUR 0.7bn8bn → FY25(prior: EUR 0.8bn (+17% LFL7bn) <sup>p. 20</sup>.
* ''Short-term margin'' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn <sup>p. 20</sup>
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
 
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 635 ⟶ 573:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ UnderlyingEarnings earningsand bynet segment,income breakdown FY24 vs FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (constant FX)
|-
| style="text-align:left" | Property & Casualty
Line 659 ⟶ 597:
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | ''Underlying earnings''
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | o/w capital gains from AXA IM disposal
| style="text-align:right" | -
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total underlying''Net earningsincome''
| style="text-align:right; font-weight:bold" | 87.19
| style="text-align:right; font-weight:bold" | 9.8.4
| style="text-align:right; font-weight:bold" | +626%
|}
</div>
Line 670 ⟶ 628:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying EPSearnings per share bridge, FY24 vsto FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | FY24Underlying earnings per share
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying EPS (reported basis)FY24
| style="text-align:right" | 3.59
| style="text-align:right" | 3.86
| style="text-align:right" | +8%
|-
| style="text-align:left" | from earningsEarnings growth
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +6%
|-
| style="text-align:left" | from capitalCapital management
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +3%
|-
| style="text-align:left" | from forexForex
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | -2%
|-
| style="text-align:left" | from temporaryTemporary earnings dilution from AXA IM sale
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | -1%
|-
| style="text-align:left" | FY25
| style="text-align:right" | 3.86
|}
</div>
 
* ''Underlying earnings'' drivers:
* '''Non-financial flows''': EUR +2.1bn in FY25 vs EUR -0.5bn in FY24, including EUR +2.2bn capital gains from AXA IM disposal <sup>p. 21</sup>.
** Strong performance from insurance businesses <sup>p. 21</sup>
* '''Financial flows''': EUR -0.7bn in FY25 (including realized capital gains) vs EUR +0.3bn in FY24 <sup>p. 21</sup>.
** '''NetStable income''':holding EURcost, 9.8bnexpected into FY25remain vsat EURcurrent 7.9bnlevel in FY24 (+26% at constant FX)2026 <sup>p. 21</sup>.
* ''Net income'' drivers:
* '''Insurance business performance''': Strong performance from insurance businesses <sup>p. 21</sup>.
** '''HoldingHigher costs''':net Stableincome holdingmainly cost,reflecting expectedhigher tounderlying remainearnings atand currentthe levelgain infrom 2026the sale of AXA IM <sup>p. 21</sup>.
** '''Net income drivers''': Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM; lowerLower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>.
* IncludesChange <code>-1%</code>is at constant fromFX temporaryfor underlying earnings dilutionand fromnet AXAincome; IMchange saleis dueon toa thereported timingbasis offor anti-dilutiveunderlying earnings per share buyback <sup>p. 21</sup>.
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
 
=== Shareholders' equity ===
== FY25 Financial Performance ==
 
===* (stacked bar) ''Shareholders' Equityequity'' Group ===share:
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''HY25'': EUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and Net OCI EUR -7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity and related metricsroll-forward <sup>p. 22</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | ''Opening Shareholders' equity (Group share)''
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
|-
| style="text-align:left" | SHE excl. OCI
| style="text-align:right" | 58.0
| style="text-align:right" | 52.7
| style="text-align:right" | 54.0
|-
| style="text-align:left" | Net OCI
| style="text-align:right" | -8.1
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity bridge, FY24 to FY25 <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | Opening SHE
| style="text-align:right" | 49.9
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | +1.3
| style="text-align:right" | 0.4
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" | +9.8
| style="text-align:right" | 5.9
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | -
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | 0.3
|-
| style="text-align:left" | ''Closing SHEShareholders' equity''
| style="text-align:right" | 47.2
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity bridge, HY25 to FY25 <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | Opening SHE
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | +0.4
|-
| style="text-align:left" | Net income
| style="text-align:right" | +5.9
|-
| style="text-align:left" | Anti-dilutive share buyback
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | +0.3
|-
| style="text-align:left" | Closing SHE
| style="text-align:right" | 47.2
|}
Line 827 ⟶ 722:
=== Higher organic cash remittance and robust cash position at Holding ===
 
* (bar) ''Net cash remittance'' trend:
<div style="overflow-x:auto">
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
{| class="wikitable fintable"
|+** Net''FY25'': cashEUR remittance7.5bn total <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Net cash remittance
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Ordinary remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
|-
| style="text-align:left" | In-force treaties proceeds
| style="text-align:right" | 0.6
| style="text-align:right" | —
|}
</div>
 
* In-force treaties proceeds in FY24 related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.
* Remittance ratio: 82% in FY25 (FY24: 82%)
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge, FY24 to FY25 in Euro billion <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
| style="text-align:left" | Net cash remittance from subsidiaries
| style="text-align:right" | +7.5
|-
Line 869 ⟶ 745:
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Holding costs and interest expenses
| style="text-align:right" | -1.3
|-
Line 881 ⟶ 757:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
</div>
 
* Holding costs include interest expenses.
* Anti-dilutive share buyback following the sale of AXA IM.
 
=== Solvency II at 224% ===
Line 897 ⟶ 770:
! class="col-s" style="text-align:right" | EOF
! class="col-s" style="text-align:right" | SCR
! class="col-s" style="text-align:right" | Solvency II ratio (%pts)
|-
| style="text-align:left" | FY24
Line 924 ⟶ 797:
| style="text-align:right" | +4
|-
| style="text-align:left" | Dividend & annual share buyback
| style="text-align:right" | -6.0
| style="text-align:right" | 0.0
| style="text-align:right" | -24
|-
| style="text-align:left" | Management actions, debt & other
| style="text-align:right" | -0.1
| style="text-align:right" | -0.2
Line 941 ⟶ 814:
</div>
 
* Foreseeable dividends accounted for -EUR 4.8bn.
* Dividend & buyback comprises foreseeable dividends of EUR -4.8bn and provision for annual share buyback for 2026 of EUR -1.25bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
* Management actions include debt & other.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities of Solvency II sensitivitiesratio (impactas onof 224%December 31, 2025 (base 224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 965 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity +25% (excl.excluding PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity -25% (excl.excluding PE & Infra) -25%
| style="text-align:right" | +2
|-
Line 982 ⟶ 855:
</div>
 
* Euro Sovereignsovereign spreads +50bpssensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter / (3 notches).
 
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
 
<div style="overflow-x:auto">
* '''Solvency II ratio''' as of December 31, 2025: 224% <sup>p. 25</sup>
{| class="wikitable fintable"
* '''Grandfathering period end''': Impact of -10pts to 215% on January 1, 2026 <sup>p. 25</sup>
|+ Solvency II ratio impacts <sup>p. 25</sup>
** EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026 <sup>p. 25</sup>
! style="text-align:left" | Event
* '''Solvency II revision''': Estimated impact of +17pts (to come into effect in 1Q27) <sup>p. 25</sup>
! class="col-s" style="text-align:right" | Impact (pts)
** No change expected in organic capital generation <sup>p. 25</sup>
|-
** Additional capital flexibility <sup>p. 25</sup>
| style="text-align:left" | Solvency II ratio as of December 31, 2025
** Estimated based on SCR and EOF under Solvency II as of January 1, 2026, as if the revision had come into force on that date <sup>p. 25</sup>
| style="text-align:right" | 224
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10
|-
| style="text-align:left" | Solvency II revision impact to come into effect in 1Q27
| style="text-align:right" | +17
|}
</div>
 
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
* No change is expected in organic capital generation.
* Provides additional capital flexibility.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
 
=== Thomas Buberl, Group CEO conclusion ===
 
* '''Section divider''' featuringfor the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>.
 
=== Conclusion ===
 
* '''Record results''' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* '''All businesses''' in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''' well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* '''Laying foundations''' for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
 
=== February 26, 2026 Q&A Full Year 2025 earnings ===
 
* '''SectionQ&A divider'session'' for Q&Athe sessionFull Year 2025 Earnings presentation held on February 26, 2026 <sup>p. 28</sup>.
 
=== AXA Investor Relations | Keep in touch ===
 
* ''Investor Relations contact'': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
* '''Meet our management''' event calendar:
** March''Follow us'': Roadshows in Europe and USwww.axa.com <sup>p. 29</sup>
 
** May 5: 1Q25 Activity Indicators in Paris <sup>p. 29</sup>
<div style="overflow-x:auto">
** June 2: BNP Paribas Exane CEO Conference in Paris <sup>p. 29</sup>
{| class="wikitable"
** June 2-4: Goldman Sachs European Financials Conference in Zurich <sup>p. 29</sup>
**|+ JulyMeet 31:our HY26management Earningsevent Release in Parisschedule <sup>p. 29</sup>
! style="text-align:left" | Date
** September 21: AXA Investor Day in London <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Event
* '''Contact us''' details: Investor Relations phone +33 1 40 75 48 42; email investor.relations@axa.com <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Location
* '''Follow us''' website: www.axa.com <sup>p. 29</sup>
|-
| style="text-align:left" | March
| class="col-m" style="text-align:right" | Roadshows
| class="col-m" style="text-align:right" | Europe and US
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>
 
== Appendices ==
 
* '''Section divider for ''Appendices'' for appendices <sup>p. 30</sup>
 
=== Table of contents ===
 
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ AdditionalGross disclosuresfinancial by topic and pagedebt <sup>p. 3132</sup>
! style="text-align:left" | TopicEUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | PageFY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1st 2026
|-
| style="text-align:left" | DebtTier and Invested Assets1
| style="text-align:right" | 314.8
| style="text-align:right" | 4.6
| style="text-align:right" | 3.2
|-
| style="text-align:left" | AdditionalTier P&C disclosures2
| style="text-align:right" | 3610.8
| style="text-align:right" | 12.2
| style="text-align:right" | 11.3
|-
| style="text-align:left" | AdditionalSenior IFRS17 disclosuresdebt
| style="text-align:right" | 413.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8
|-
| style="text-align:left; font-weight:bold" | SustainabilityTotal
| style="text-align:right; font-weight:bold" | 4419.2
| style="text-align:right; font-weight:bold" | 20.3
| style="text-align:right; font-weight:bold" | 20.3
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
{| class="wikitable fintable"
|+ Contractual maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2028
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 10.8
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (contractual)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
* (stacked bar) '''Gross financial debt''':
{| class="wikitable fintable"
** '''FY24''': EUR 19.2bn total (Tier 1: EUR 4.8bn, Tier 2: EUR 10.8bn, Senior debt: EUR 3.5bn); debt gearing at 20.6% <sup>p. 32</sup>
|+ Economic maturity breakdown <sup>p. 32</sup>
** '''FY25''': EUR 20.3bn total (Tier 1: EUR 4.6bn, Tier 2: EUR 12.2bn, Senior debt: EUR 3.5bn); debt gearing at 22.3% <sup>p. 32</sup>
! style="text-align:left" | EUR billion
** '''Jan 1st 2026''' (End of the grandfathering period): EUR 20.3bn total (Tier 1: EUR 3.2bn, Tier 2: EUR 11.3bn, Senior debt: EUR 5.8bn, of which EUR 0.4bn redeemed in Jan 2026) <sup>p. 32</sup>
! class="col-s" style="text-align:right" | Tier 1
* (bar chart) '''Contractual maturity breakdown''':
! class="col-s" style="text-align:right" | Tier 2
** '''2028''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
! class="col-s" style="text-align:right" | Senior debt
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn, Senior debt: EUR 0.2bn) <sup>p. 32</sup>
|-
** '''2031-2039''': EUR 1.5bn (Senior debt) <sup>p. 32</sup>
| style="text-align:left" | 2026
** '''≥2040''': EUR 11.3bn total (Tier 2: EUR 10.8bn, Senior debt: EUR 0.5bn) <sup>p. 32</sup>
| style="text-align:right" | 0.1
** '''Undated''': EUR 5.3bn total (Tier 1: EUR 4.6bn, Tier 2: EUR 0.7bn) <sup>p. 32</sup>
| style="text-align:right" | —
** '''Of which Grandfathered debt (Contractual)''': Tier 1 Undated: EUR 1.4bn; Tier 2 2030: EUR 0.7bn, ≥2040: EUR 0.2bn <sup>p. 32</sup>
| style="text-align:right" | —
* (bar chart) '''Economic maturity breakdown''':
|-
** '''2026''': EUR 0.1bn (Tier 1) <sup>p. 32</sup>
| style="text-align:left" | 2027
** '''2027''': EUR 2.4bn (Tier 2) <sup>p. 32</sup>
| style="text-align:right" | —
** '''2028''': EUR 0.6bn total (Tier 1: EUR 0.1bn, Senior debt: EUR 0.5bn) <sup>p. 32</sup>
| style="text-align:right" | 2.4
** '''2029''': EUR 2.0bn (Tier 2) <sup>p. 32</sup>
| style="text-align:right" | —
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn, Senior debt: EUR 0.2bn) <sup>p. 32</sup>
|-
** '''2031-2039''': EUR 1.5bn total (Tier 1: EUR 0.4bn, Tier 2: EUR 1.1bn) <sup>p. 32</sup>
| style="text-align:left" | 2028
** '''≥2040''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
| style="text-align:right" | 0.1
** '''Undated''': EUR 4.7bn total (Tier 1: EUR 4.0bn, Tier 2: EUR 0.7bn) <sup>p. 32</sup>
| style="text-align:right" | —
** '''Of which Grandfathered debt (Economic)''': Tier 1: 2026: EUR 0.1bn, 2028: EUR 0.1bn, 2031-2039: EUR 0.4bn, Undated: EUR 0.8bn; Tier 2: 2030: EUR 0.7bn, ≥2040: EUR 0.2bn <sup>p. 32</sup>
| style="text-align:right" | 0.5
* '''Redemption actions''': In January 2026, AXA called the remaining T2 GF GBP 139m due 2054 callable 2034 5.625% issued January 2014, and the T1 GF EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>.
|-
* '''Economic maturity definition''': Takes into account the first date of step-up calls on institutionally placed subordinated debt; Solvency II RT1 debt has no step-up, so its undated nature is retained <sup>p. 32</sup>.
| style="text-align:left" | 2029
| style="text-align:right" | —
| style="text-align:right" | 2.0
| style="text-align:right" | —
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (economic)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
 
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
=== General Account invested assets ===
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
 
=== General account invested assets ===
 
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25Invested Totalassets Generalbreakdown Account invested assetsFY25 <sup>p. 33</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | ValueFY25
! class="col-s" style="text-align:right" | Share%
|-
| style="text-align:left" | ''Fixed income''
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left" | ''o/w Government bonds''
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left" | ''o/w Corporate bonds and loans''
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''o/w Other fixed income''
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | ''Real estate''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | ''Infrastructure equity''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Listed equities''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Private equity and hedge funds''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | ''Cash''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | ''Policy loans''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left; font-weight:bold" | ''Total Insurance Invested Assets''
| style="text-align:right; font-weight:bold" | 450
| style="text-align:right; font-weight:bold" | 100%
|}
</div>
 
=== Structured and private credit assets ===
* Total General Account invested assets: EUR 450bn total, with a duration gap at -0.4 year
* Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn)
* Listed equities includes hedges (listed equities excluding hedges at EUR 14bn)
* Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn)
 
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
=== Structured and Private Credit assets ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured and Privateprivate Creditcredit Assetsassets breakdown FY25 <sup>p. 34</sup>
! style="text-align:left" | Invested assets (100%) in EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | ValueFY25
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
! class="col-m" style="text-align:right" | Comments
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | ''Total Structured and Private Credit Assets''
| style="text-align:right; font-weight:bold" | ''69''
| style="text-align:right; font-weight:bold" | ''15%''
| style="text-align:right" | o/w 54% participating
|}
</div>
 
* ''General Account'' (G/A) represents the investment portfolio <sup>p. 34</sup>.
* Residential Mortgages: EUR 6bn Dutch mortgages, NHG guaranteed; EUR 10bn self-originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
* CLO & ABS: 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
* Infrastructure debt: skewed towards resilient industries (Telecom, Utilities, Transport)
* CRE debt: strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
* Mid-Market lending: strong diversification with EUR 8m average ticket; investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
* Total Structured and Private Credit Assets: 54% participating
 
=== Investment portfolio | Fixed Incomeincome reinvestment ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment asset mix <sup>p. 35</sup>
! style="text-align:left" | EURAsset billion unless otherwise mentionedmix
! class="col-s" style="text-align:right" | Share
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
| style="text-align:right" | —
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
|-
| style="text-align:right" | —
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
| style="text-align:right" | —
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
|}
| style="text-align:right" | —
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | Fixed Income Type
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | —
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | —
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | Total fixed income
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 3.9%
|}
</div>
 
* Fixed income reinvestment totaled EUR 57bn in FY25 <sup>p. 35</sup>
* Reinvestment highlights:
** EURReinvestment 57bnyield fixed income investedachieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Includes EUR 19.7bn of Private & Structured Credit investedreinvestment of EUR 19.7bn at 4.7% (yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY) <sup>p. 35</sup>
** GradualStrategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
 
=== Table of contents ===
* '''Additional P&C disclosures''' is covered on page 36 <sup>p. 36</sup>.
 
* Other sections in the appendix include Debt and Invested Assets on page 31, Additional IFRS17 disclosures on page 41, and Sustainability on page 44 <sup>p. 36</sup>.
* ''Debt and Invested Assets'' on page 31 <sup>p. 36</sup>
* ''Additional P&C disclosures'' on page 36 <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' on page 41 <sup>p. 36</sup>
* ''Sustainability'' on page 44 <sup>p. 36</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,230 ⟶ 1,297:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP breakdownby line of business <sup>p. 37</sup>
! style="text-align:left" | USDLine billionof unless otherwise mentionedbusiness
! class="col-s" style="text-align:right" | GWP by lineShare
! class="col-s" style="text-align:right" | GWP by geography
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
| style="text-align:right" | —
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
| style="text-align:right" | —
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
| style="text-align:right" | —
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|}
| style="text-align:right" | —
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Americas
| style="text-align:right" | —
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | —
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | —
| style="text-align:right" | 19%
|}
</div>
 
<div style="overflow-x:auto">
* Market position: Top 3 globally in Multinational Programs, Marine, and Fine Art & Specie <sup>p. 37</sup>.
{| class="wikitable"
* (bubble chart) Cycle management: Property has the highest profitability and highest ex-price growth; Specialty has medium profitability and medium ex-price growth; Casualty has medium-low profitability and medium-low ex-price growth; Professional lines has the lowest profitability and lowest ex-price growth <sup>p. 37</sup>.
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
 
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* Cycle management is utilized to deliver consistent profitability <sup>p. 37</sup>
* ''Property'': high profitability, high ex-price growth <sup>p. 37</sup>
* ''Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
* ''Casualty'': medium profitability, medium ex-price growth <sup>p. 37</sup>
* ''Professional lines'': lower profitability, lower ex-price growth <sup>p. 37</sup>
 
=== P&C | Focus on Reservesreserves ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and technical reserves ratios by IFRS basis <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
Line 1,283 ⟶ 1,383:
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179%
| style="text-align:right" | 185%
| style="text-align:right" | 193%
| style="text-align:right" | 188%
| style="text-align:right" | 189%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 198%
| style="text-align:right" | 195%
| style="text-align:right" | 180%
| style="text-align:right" | 175%
|-
| style="text-align:left" | Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 213%
| style="text-align:right" | 227%
| style="text-align:right" | 233%
| style="text-align:right" | 226%
| style="text-align:right" | 227%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Technical reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 234%
| style="text-align:right" | 232%
| style="text-align:right" | 216%
| style="text-align:right" | 210%
|}
</div>
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
 
=== P&C | 2026 Simplified Group Nat Cat Reinsurancereinsurance Programprogram 1 ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ReinsuranceInsurance capacitysegment andoccurrence retention by perilprotection <sup>p. 39</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Capacity
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
| style="text-align:right" | 4.0
| style="text-align:right" | 600m
| style="text-align:right" | 4.0bn
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" | 2.1
| style="text-align:right" | 450m
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 2.1
| style="text-align:right" | 400m
| style="text-align:right" | 2.1bn
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 1.2
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 1.2
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | OtherPer other perils
| style="text-align:right" | —
| style="text-align:right" | 400m
| style="text-align:right" | Varies by peril type
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
 
* (diagram) ''Reinsurance segment'' (illustrative):
* Retention levels: Stable retention levels maintained in 2026 as in 2025.
* Covered via ''Alternative Capital & Cat Bonds'' <sup>p. 39</sup>
* NA Hurricane: varying retention between MX at EUR 400m and NA at EUR 600m.
* NA Earthquake: varying retention between MX at EUR 400m and NA at EUR 600m.
* Other perils: includes Turkey earthquake, other Europe and NA perils, South America Earthquake, and other secondary perils.
* Reinsurance segment: Alternative Capital & Cat Bonds utilized.
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
 
<div style="overflow-x:auto">
* '''Nat Cat definition''': Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>.
{| class="wikitable fintable"
* '''Deviation baseline''': Compared to a normalized level of costs expected in an average year, which is ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance <sup>p. 40</sup>.
* (bar) '''Earnings deviation''':|+ Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax <sup>p. 40</sup>.
! style="text-align:left" | Return period / probability percentile
** '''More severe years''': Negative deviation in ca. 40% of cases; 1/20y (95th percentile) EUR -1.2bn, 1/10y (90th percentile) EUR -0.8bn, 1/5y (80th percentile) EUR -0.4bn <sup>p. 40</sup>.
! class="col-s" style="text-align:right" | EUR billion
** '''Median''': 50th percentile at EUR +0.1bn <sup>p. 40</sup>.
|-
** '''Less severe years''': Positive deviation in ca. 60% of cases; 1/5y (20th percentile) EUR +0.5bn, 1/10y (10th percentile) EUR +0.7bn, 1/20y (5th percentile) EUR +0.8bn <sup>p. 40</sup>.
| style="text-align:left" | 1/20y (95th percentile)
* (bar) '''Expected Nat Cat''': Average expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>.
| style="text-align:right" | -1.2
** '''FY25''': EUR 2.6bn (Estimated impact on GEP: ca. 4.5%) <sup>p. 40</sup>.
|-
** '''FY26''': EUR 2.7bn (Estimated impact on GEP: ca. 4.5%) <sup>p. 40</sup>.
| style="text-align:left" | 1/10y (90th percentile)
| style="text-align:right" | -0.8
|-
| style="text-align:left" | 1/5y (80th percentile)
| style="text-align:right" | -0.4
|-
| style="text-align:left" | Median (50th percentile)
| style="text-align:right" | +0.1
|-
| style="text-align:left" | 1/5y (20th percentile)
| style="text-align:right" | +0.5
|-
| style="text-align:left" | 1/10y (10th percentile)
| style="text-align:right" | +0.7
|-
| style="text-align:left" | 1/20y (5th percentile)
| style="text-align:right" | +0.8
|}
</div>
 
<div style="overflow-x:auto">
* '''Table of contents''' <sup>p. 41</sup>:
{| class="wikitable"
** 1. Debt and Invested Assets <sup>p. 31</sup>
**|+ 2.Average expected Nat Cat charges net Additionalof P&Creinsurance, disclosurespre-tax <sup>p. 3640</sup>
! style="text-align:left" | Year
** 3. '''Additional IFRS17 disclosures''' <sup>p. 41</sup>
! class="col-s" style="text-align:right" | EUR billion
** 4. Sustainability <sup>p. 44</sup>
! class="col-s" style="text-align:right" | Estimated impact on GEP
|-
| style="text-align:left" | 2025
| class="col-s" style="text-align:right" | 2.6
| class="col-s" style="text-align:right" | ca. 4.5%
|-
| style="text-align:left" | 2026
| class="col-s" style="text-align:right" | 2.7
| class="col-s" style="text-align:right" | ca. 4.5%
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
* ''Less severe years'' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
 
=== Table of contents ===
 
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== P&C | Margin analysis ===
Line 1,388 ⟶ 1,526:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C margin analysis, FY25and vsunderlying FY24earnings at constant FXFY25 <sup>p. 42</sup>
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change vs FY24
! class="col-m" style="text-align:right" | Other metrics
|-
| style="text-align:left" | ''Current Accident Year Undiscounted Technical Margin''
| style="text-align:right" | 2,778
| style="text-align:right" | +707
| style="text-align:right" | —
|-
| style="text-align:left" | Gross''Current EarnedAccident PremiumsYear Discounting''
| style="text-align:right" | 57,656
| style="text-align:right" | +6%
| style="text-align:right" | —
|-
| style="text-align:left" | Current Accident Year Undiscounted Combined Ratio
| style="text-align:right" | 95.2%
| style="text-align:right" | -1.0pt
| style="text-align:right" | —
|-
| style="text-align:left" | Nat Cats
| style="text-align:right" | 3.4%
| style="text-align:right" | -0.4pt
| style="text-align:right" | —
|-
| style="text-align:left" | Current Accident Year Discounting
| style="text-align:right" | 2,009
| style="text-align:right" | +115
| style="text-align:right" | —
|-
| style="text-align:left" | Discounting Ratio (in Combined Ratio points)
| style="text-align:right" | -3.5%
| style="text-align:right" | +0.0pt
| style="text-align:right" | —
|-
| style="text-align:left" | Current Accident Year Net Claims reserves
| style="text-align:right" | 19.0bn
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Duration
| style="text-align:right" | 4.0 years
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Current Accident Year Discount rate
| style="text-align:right" | 2.8%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | ''Prior Years' Reserve Development (PYD)''
| style="text-align:right" | 622
| style="text-align:right" | -341
| style="text-align:right" | —
|-
| style="text-align:left" | PYD''Investment ratioIncome''
| style="text-align:right" | -1.1%
| style="text-align:right" | +0.7pt
| style="text-align:right" | —
|-
| style="text-align:left" | Investment Income
| style="text-align:right" | 3,988
| style="text-align:right" | +435
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Average Assets
| style="text-align:right" | 115bn
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Asset book yield
| style="text-align:right" | 3.5%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Reinvestment yield (on fixed income assets)
| style="text-align:right" | 4.3%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | ''Insurance Finance Expenses''
| style="text-align:right" | -1,358
| style="text-align:right" | -235
| style="text-align:right" | —
|-
| style="text-align:left" | FY24''Underlying ReservesEarnings atbefore locked-in ratetax''
| style="text-align:right" | 71bn
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Liability book yield
| style="text-align:right" | 1.9%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Underlying Earnings before tax
| style="text-align:right" | 8,040
| style="text-align:right" | +681
| style="text-align:right" | —
|-
| style="text-align:left" | Tax
| style="text-align:right" | -2,060
| style="text-align:right" | -169
| style="text-align:right" | —
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | -108
| style="text-align:right" | -10
| style="text-align:right" | —
|-
| style="text-align:left" | ''Underlying Earnings''
| style="text-align:right" | 5,872
| style="text-align:right" | +501
| style="text-align:right" | growth vs. FY24 at constant FX of +9%
|}
</div>
 
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
<div style="overflow-x:auto">
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
{| class="wikitable fintable"
|+* FY25''Discounting sensitivityratio'' to-3.5% Current Accident(+0.0pt Yearin discountCombined rateRatio changespoints) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
! style="text-align:left" | Change in discount rate
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
! class="col-s" style="text-align:right" | Impact (EUR billion)
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
|-
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
| style="text-align:left" | +25bps
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
| style="text-align:right" | +0.2
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
|-
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
| style="text-align:left" | -25bps
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
| style="text-align:right" | -0.2
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
|}
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
</div>
 
=== L&H | Margin analysis ===
<div style="overflow-x:auto">
{| class="wikitable"
|+ 2026e Insurance Finance Expenses (pre-tax) and sensitivity <sup>p. 42</sup>
! style="text-align:left" | Item
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | 2026e Insurance Finance Expenses (pre-tax)
| class="col-s" style="text-align:right" | ~ -1.4bn
|-
| style="text-align:left" | Sensitivity to 2025 current AY Discount +25bps
| class="col-s" style="text-align:right" | ~ -50m
|-
| style="text-align:left" | Sensitivity to 2025 current AY Discount -25bps
| class="col-s" style="text-align:right" | ~ +50m
|}
</div>
 
===* ''L&H | Marginmargin analysis'' includes scope impact <sup>p. ===43</sup>.
* ''Short-term technical margin'' +EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ L&HTechnical marginand analysis,financial FY25results vsin FY24Euro at constantmillion, FXpre-tax <sup>p. 43</sup>
! style="text-align:left" | EURTechnical millionand unlessFinancial otherwise mentionedResults
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change vs FY24
! class="col-m" style="text-align:right" | Other metrics
|-
| style="text-align:left" | Short-term Technical Margin
| style="text-align:right" | 479
| style="text-align:right" | +60
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Earned Premiums
| style="text-align:right" | 17,416
| style="text-align:right" | +10%
| style="text-align:right" | —
|-
| style="text-align:left" | All Year Combined Ratio
| style="text-align:right" | 97.2%
| style="text-align:right" | -0.1pt
| style="text-align:right" | includes recapture of Laya
|-
| style="text-align:left" | Long-term Technical Margin
| style="text-align:right" | 2,804
| style="text-align:right" | +156
| style="text-align:right" | —
|-
| style="text-align:left" | CSM release
| style="text-align:right" | 2,954
| style="text-align:right" | +215
| style="text-align:right" | —
|-
| style="text-align:left" | Technical experience
| style="text-align:right" | -150
| style="text-align:right" | -58
| style="text-align:right" | —
|-
| style="text-align:left" | Investment Income (non-VFA only)
| style="text-align:right" | 2,484
| style="text-align:right" | -1
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Average Assets
| style="text-align:right" | 98bn
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Asset book yield
| style="text-align:right" | 2.5%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Reinvestment yield (on fixed income assets)
| style="text-align:right" | 3.8%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Insurance Finance Expenses (non-VFA only)
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|}
| style="text-align:right" | —
</div>
|-
 
| style="text-align:left" | FY24 Reserves at locked-in rate
|<div style="textoverflow-alignx:rightauto" | 62bn>
{| class="wikitable fintable"
| style="text-align:right" | —
|+ Underlying earnings bridge in Euro million <sup>p. 43</sup>
| style="text-align:right" | —
! style="text-align:left" | Underlying Earnings
|-
|! class="col-s" style="text-align:leftright" | Liability book yieldFY25
|! class="col-s" style="text-align:right" | 2.5%Change
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Underlying Earnings before tax
| style="text-align:right" | 4,229
| style="text-align:right" | +205
| style="text-align:right" | —
|-
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" | +65
| style="text-align:right" | —
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | 72
| style="text-align:right" | -51
| style="text-align:right" | —
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:right" | 3,501
| style="text-align:right" | +219
| style="text-align:right" | growth vs. FY24 at constant FX of +7%
|}
</div>
 
* ''Underlying earnings growth'' +7% versus FY24 at constant FX <sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM Keykey Sensitivitiessensitivities in Euro billion <sup>p. 43</sup>
! style="text-align:left" | ScenarioSensitivity
! class="col-s" style="text-align:right" | EUR billionImpact
|-
| style="text-align:left" | Baseline
Line 1,647 ⟶ 1,662:
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" | +0.6
|-
| style="text-align:left" | Sovereign spreads +50bps
Line 1,653 ⟶ 1,668:
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" | +1.9
|-
| style="text-align:left" | Corporate spread +50bps
Line 1,659 ⟶ 1,674:
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | +0.7
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" | +1.8
|-
| style="text-align:left" | Equities -25%
Line 1,669 ⟶ 1,684:
</div>
 
*=== '''Table of contents''' <sup>p. 44</sup>:===
 
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2.''Debt Additionaland P&CInvested disclosuresAssets'' <sup>p. 3631</sup>
** 3. ''Additional IFRS17P&C disclosures'' <sup>p. 4136</sup>
** 4. '''Sustainability'Additional IFRS17 disclosures'' <sup>p. 4441</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,679 ⟶ 1,695:
<div style="overflow-x:auto">
{| class="wikitable"
|+ SustainabilityESG targets and 2025 resultsachievements <sup>p. 45</sup>
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025Achieved Resultin 2025
|-
| style="text-align:left" | Climate transition financing
Line 1,692 ⟶ 1,708:
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | P&C GWP to support transitionTransition underwriting (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions & services (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
| style="text-align:left" | Inclusive insurance customers
Line 1,704 ⟶ 1,720:
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" | AXAClimate Groupadaptation employees trained on climate adaptationtraining
| class="col-m" style="text-align:right" | >80,000 employees by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Absolute carbonCarbon emissions reduction
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64% reduction against 2019
|-
| style="text-align:left" | Employee volunteering engagement
| class="col-m" style="text-align:right" | 50% of AXA Group employees engaged in volunteering activities by 2026
| class="col-m" style="text-align:right" | 56%
|}
</div>
* '''Climate adaptation solutions & services''' target (cumulative 2024-2026): >20,000 (target revised in 2025 from >9,000); 2025 Result: 19,698 cumulative 2024-2025 <sup>p. 45</sup>
* '''Absolute carbon emissions reduction''' target: -50% by 2030 (against 2019 baseline; scope: energy Scopes 1 and 2, car fleet and business travel) and offset of residual emissions; 2025 Result: -64% reduction against 2019 <sup>p. 45</sup>
 
=== Sustainability Performance & Ratings ===
Line 1,724 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG ratings and scores <sup>p. 46</sup>
! style="text-align:left" | ProviderRating Agency
! class="col-ms" style="text-align:right" | 2025 Score / Rating
|-
| style="text-align:left" | S&P Global percentile
| class="col-ms" style="text-align:right" | 97th percentile¹ in Dow Jones Best-in-Class Europe & World indices
|-
| style="text-align:left" | MSCI
| class="col-ms" style="text-align:right" | AAA
|-
| style="text-align:left" | CDP
| class="col-ms" style="text-align:right" | B
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-ms" style="text-align:right" | 17.0 - Low risk
|-
| style="text-align:left" | FTSE Russell
| class="col-ms" style="text-align:right" | 4.3/5 in FTSE4Good Index Series
|}
</div>
 
* "The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results as of February 6th, 2026."
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup>
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
 
=== Scope ===
 
* '''France''': scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''': scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''': scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''': scope includes: <sup>p. 47</sup>
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated, and; China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance activities and holding) and, Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) which are fully consolidated, as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>.
** '''AXA Mediterranean Holdings''' <sup>p. 47</sup>.
* '''Transversal & Other''': scope includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers''' (until July 1, 2025): scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* '''Accounting standards''': Unless otherwise specified herein, all comparative figures going back to 2023 are under the IFRS17/9 accounting standards that became (effective on January 1, 2023); figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4 <sup>p. 47</sup>.
 
=== Glossary ===
 
* '''Capital-light G/A products''': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup>
* '''Contractual Service Margin''' (CSM)'': a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders <sup>p. 48</sup>
* '''CSM release''': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup>
* '''Economic variance''': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup>
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>
* '''Gross Written Premiums''' and Other Revenues (GWP & Other Revenues)'': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business);. Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>
* '''New Business Value''' (NBV)'': the value of newly issued contracts during the current year,. It consistingconsists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>
* '''New Business CSM'''Contractual Service Margin (NB CSM)'': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>
* '''New Business Value margin''' (NBV margin)'': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes;. operatingOperating variance is net of reinsurance <sup>p. 48</sup>
* '''Present value of expected premiums''' (PVEP)'': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term;. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>
* '''Technical experience''': consists of the impacts on the underlying earnings of (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
 
=== February 26, 2026 Thank you Full Year 2025 earnings ===
 
* '''PresentationClosing conclusion'slide'': for the AXA Full Year 2025 Earnings presentation, concluded ondated February 26, 2026 <sup>p. 49</sup>.
 
== Abbreviations ==
 
* '''AA''': Senior bond rating (Standard & Poor's)
* '''AAA''': Senior bond rating (Standard & Poor's)
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* ''AMF'': Autorité des marchés financiers
* '''APAC''': Asia-Pacific
* '''AXA IM'APAC'': AXA Investment ManagersAsia-Pacific
* ''AXA IM'': AXA Investment Managers
* '''AXA XL''': AXA XL (AXA's large property and casualty commercial lines and specialty risk division)
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* '''AY''': Accident Year
* ''AY'': Accident Year
* '''BBA''': Beneficial interest in a Block of business of Annuities
* '''CDP'BBA'': Carbon DisclosureBenefit-Bearing ProjectAccount
* '''CLO'CDP'': CollateralizedCarbon LoanDisclosure ObligationProject
* '''CRE'CLO'': CommercialCollateralized RealLoan EstateObligation
* '''CSA'CRE'': CorporateCommercial SustainabilityReal AssessmentEstate
* ''CSA'': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY'CSM'': CalendarContractual Service YearMargin
* '''DPS'CY'': Dividend PerCalendar ShareYear
* '''EME'DPS'': EmergingDividend Per MarketsShare
* '''EOF'EME'': Eligible OwnEmerging FundsMarkets
* '''EPS'EOF'': EarningsEligible PerOwn ShareFunds
* ''EPS'': Earnings Per Share
* '''ESG''': Environmental, Social, and Governance
* ''ESG'': Environmental, Social, and Governance
* '''EU''': European Union
* ''ESMA'': European Securities and Markets Authority
* '''EUR''': Euro
* '''FX'EU'': ForeignEuropean ExchangeUnion
* ''EUR'': Euro
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP'FX'': Gross EarnedForeign PremiumsExchange
* ''GAAP'': Generally Accepted Accounting Principles
* '''GF EUR''': Grandfathered Euro
* '''GF GBP''': Grandfathered Great British Pound
* '''GWP'GEP'': Gross WrittenEarned PremiumsPremium
* '''HKD'GWP'': HongGross KongWritten DollarPremiums
* '''HY'HKD'': HighHong Kong YieldDollar
* '''IFE'HY'': Insurance FinanceHigh ExpensesYield
* ''IFE'': Insurance Finance Expenses
* '''IFRS''': International Financial Reporting Standards
* ''IFRS'': International Financial Reporting Standards
* '''IG''': Investment Grade
* '''JPY'IG'': JapaneseInvestment YenGrade
* '''LATAM'JPY'': LatinJapanese AmericaYen
* '''LFL'LATAM'': Like-for-LikeLatin America
* '''LTV'LFL'': LoanLike-tofor-ValueLike
* ''LTV'': Loan-to-Value
* '''MSCI''': Morgan Stanley Capital International
* ''MSCI'': Morgan Stanley Capital International
* '''MX''': Mexico
* '''NA''': North America
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie (National Mortgage Guarantee)
* '''NPS''': Net Promoter Score
* '''OCI''': Other Comprehensive Income
* '''PAA''': PremiumParticipating AllocationAccount ApproachAgreement
* '''PE''': Private Equity
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''ROE'RCG'': ReturnReinsurance OnCapital EquityGeneration
* '''SCR'ROE'': SolvencyReturn Capitalon RequirementEquity
* '''SHE'SCR'': Shareholders'Solvency Capital EquityRequirement
* ''SHE'': Shareholders' Equity
* '''SME''': Small and Medium-sized Enterprises
* ''SME'': Small and Medium-sized Enterprises
* '''TVOG''': Time Value of Options & Guarantees
* '''UEPS'TVOG'': UnderlyingTime Value of EarningsOptions Perand ShareGuarantees
* '''UK'UEPS'': UnitedUnderlying Earnings Per KingdomShare
* '''US'UK'': United StatesKingdom
* '''USD'US'': United States Dollar
* '''VAT''': Value Added Tax
* '''VFA''': Variable Fee Approach